Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Oncotarget|December 20, 2017
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO studyJuliette Palle, David Tougeron, Astrid Pozet, et al.
The New England Journal of Medicine|June 2, 2025
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric CancerKohei Shitara, Eric Van Cutsem, Mahmut Gümüş, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 10, 2022
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instabilityClaire Boyer, David Sefrioui, Romain Cohen, et al.
BMJ (Clinical Research Ed.)|April 20, 2022
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trialZhihao Lu, Junye Wang, Yongqian Shu, et al.
JAMA Oncology|April 4, 2024
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical TrialDavid Tougeron, Laetitia Dahan, Ludovic Evesque, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2024
Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trialDamien Botsen, Sylvie Chabaud, Hervé Perrier, et al.
Clinical Chemistry|June 3, 2016
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer BiomarkerSonia Garrigou, Geraldine Perkins, Fanny Garlan, et al.
European Journal of Human Genetics : EJHG|April 16, 2015
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert-Desurmont, Françoise Charbonnier, Estelle Houivet, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Oncotarget|December 20, 2017
Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO studyJuliette Palle, David Tougeron, Astrid Pozet, et al.
The New England Journal of Medicine|June 2, 2025
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric CancerKohei Shitara, Eric Van Cutsem, Mahmut Gümüş, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 10, 2022
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instabilityClaire Boyer, David Sefrioui, Romain Cohen, et al.
BMJ (Clinical Research Ed.)|April 20, 2022
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trialZhihao Lu, Junye Wang, Yongqian Shu, et al.
JAMA Oncology|April 4, 2024
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical TrialDavid Tougeron, Laetitia Dahan, Ludovic Evesque, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2024
Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trialDamien Botsen, Sylvie Chabaud, Hervé Perrier, et al.
Clinical Chemistry|June 3, 2016
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer BiomarkerSonia Garrigou, Geraldine Perkins, Fanny Garlan, et al.
European Journal of Human Genetics : EJHG|April 16, 2015
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert-Desurmont, Françoise Charbonnier, Estelle Houivet, et al.
Pageof 13